Efficiency, costs and benefits of AOPs for removal of pharmaceuticals from the water cycle

Water Science and Technology

Volumn 61, Issue 4, 2010, Pages 985-993

  Tuerk, J ^a   Sayder, B ^b   Boergers, A ^a   Vitz, H ^a   Kiffmeyer, T K ^a   Kabasci, S ^b  

^a Institute of Energy and Environmental Technology IUTA   (Germany)

^b FRAUNHOFER INSTITUTE FOR ENVIRONMENTAL   (Germany)

Author keywords

AOP; LC MS MS; Ozone; Pharmaceuticals; Wastewater treatment

Indexed keywords

ANTIBIOTICS; BIOCHEMICAL OXYGEN DEMAND; LEAD REMOVAL (WATER TREATMENT); OXIDATION; OXIDATION RESISTANCE; OZONE; PILOT PLANTS; TOXICITY; WASTEWATER; WASTEWATER RECLAMATION; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

ADVANCED OXIDATION PROCESS; ADVANCED TECHNOLOGY; ANTINEOPLASTICS; AOP; COST-EFFICIENT; COSTS AND BENEFITS; DEGRADABILITY; LC-MS/MS; OPTIMISATIONS; OXIDATION PROCESS; PILOT PLANT SCALE; PRIVATE HOUSEHOLDS; REFERENCE SUBSTANCE; WASTEWATER STREAMS; WASTEWATER TREATMENT PLANTS; WASTEWATER TREATMENT SYSTEM; WATER CYCLE;

WATER RECYCLING;

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CHLORAMPHENICOL; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; SULFAMETHOXAZOLE;

COST-BENEFIT ANALYSIS; DEGRADATION; HYDROLOGICAL CYCLE; MASS SPECTROMETRY; OXIDATION; OZONE; PHARMACEUTICAL INDUSTRY; STREAM; TOXICITY; WATER POLLUTION; WATER TREATMENT;

AQUATIC ENVIRONMENT; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEGRADATION; DRUG ELIMINATION; HOSPITAL WASTE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; OZONATION; STREAM (RIVER); WASTE COMPONENT REMOVAL; WASTE WATER; WASTE WATER MANAGEMENT; WASTE WATER RECYCLING;

EID: 85000330688     PISSN: 02731223     EISSN: None     Source Type: Book Series    
DOI: 10.2166/wst.2010.004     Document Type: Article

References (24)

1. Beier, S., Pinnekamp, J., Schröder, H. F., Cramer, C., Mauer, C. & Selke, D. 2008 Untersuchungen zur separaten Erfassung und Behandlung von Krankenhausabwasser mit Membrantechnik und weitergehenden Verfahren. 4. Krankenhaus-Umwelttag NRW, 01.09.2008, Essen [in German ].
2. DWA Regelwerk 2009 Entwurf zum Merkblatt DWA-M 775: Abwassser aus Krankenhäusern und anderen medizinischen Einrichtungen, Aktualisierung und Überarbeitung des ATV-DVWK Merkblattes 775 (2001): Abwasser aus Krankenhäuser und anderen medizinischen Einrichtungen [both in German], Deutsche Vereinigung für Wasserwirtschaft, Abwasser und Abfall e.V., Hennef.
3. Ferk, F., Misik, M., Grummt, T., Majer, B., Fuerhacker, M., Buchmann, C., Vital, M., Uhl, M., Lenz, K., Grillitsch, B., Parzefall, W., Nersesyan, A. & Knasmuller, S. 2009 Genotoxic effects of wastewater from an oncological ward. Mutat. Res. 672(2), 69-75.
4. Golet, E. M., Alder, A. C., Hartmann, A., Ternes, T. A. & Giger, W. 2001 Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal. Chem. 73(15), 3632-3638.
5. Halling-Sorensen, B., Nielsen, N. S., Lanzky, P. F., Ingerslev, F., Lutzhoft, H. C. H. & Jorgensen, S. E. 1998 Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36(2), 357-393.
6. Hartmann, A., Golet, E., Gartiser, S., Alder, A. C., Koller, T. & Widmer, R. M. 1998 Identification of fluoroquinolone antibiotics as the main source of umuc genotoxicity in native hospital wastewater. Environ. Toxicol. Chem. 17(3), 377-382.
7. Heberer, T. 2002 Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131(1-2), 5-17.
8. Heberer, T. & Feldmann, D. 2005 Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents-modeling versus measurements. J. Hazard.Mater. 122(3), 211-218.
9. Huber, M. M., Gobel, A., Joss, A., Hermann, N., Loffler, D., McArdell, C. S., Ried, A., Siegrist, H., Ternes, T. A. & von Gunten, U. 2005 Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 39(11), 4290-4299.
10. Jolibois, B. & Guerbet, M. 2005 Evaluation of industrial, hospital and domestic wastewater genotoxicity with the Salmonella fluctuation test and the SOS chromotest. Mutat. Res. 565(2), 151-162.
11. Jorgensen, S. E. & Halling-Sorensen, B. 2000 Drugs in the environment. Chemosphere 40(7), 691-699.
12. Joss, A. & Ternes, T. A. 2006 Human Pharmaceuticals, Hormones and Fragrances-The Challenge of Micropollutants in Urban Water Management. IWA Publishing, London.
13. Joss, A., Siegrist, H. & Ternes, T. A. 2008 Are we about to upgrade wastewater treatment for removing organic micropollutants? Water Sci. Technol. 57(2), 251-255.
14. Kiffmeyer, T., Götze, H.-J., Jursch, M. & Lüders, U. 1998 Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water. Fresenius J. Anal. Chem. 361(2), 185-191.
15. Kümmerer, K. 2004 Pharmaceuticals in the Aquatic Environment-Sources, Fate, Effects and Risks. Springer-Verlag, Heidelberg.
16. Kümmerer, K., al-Ahmad, A., Bertram, B. & Wiessler, M. 2000a Biodegradability of antineoplastic compounds in screening tests: influence of glucosidation and of stereochemistry. Chemosphere 40(7), 767-773.
17. Kümmerer, K., al-Ahmad, A. & Mersch-Sundermann, V. 2000b Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 40(7), 701-710.
18. Lenz, K., Mahnik, S. N., Weissenbacher, N., Mader, R. M., Krenn, P., Hann, S., Koellensperger, G., Uhl, M., Knasmuller, S., Ferk, F., Bursch, W. & Fuerhacker, M. 2007 Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater. Water Sci. Technol. 56(12), 141-149.
19. Metzger, S., Kapp, H., Seitz, W., Weber, W. & Hiller, G. 2005 Entfernung von iodierten Röntgenkontrastmitteln bei der kommunalen Abwasserbehandlung durch den Einsatz von Pulveraktivkohle [in German]. GWF Wasser/Abwasser 146(9), 638-645.
20. Ort, C., Lawrence, M. C., Reungoat, J., Eaglesham, G., Carter, S. & Keller, J. 2009 Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Article in press, doi:10.1016/j.watres. 2009.08.002.
21. Reemtsma, T. & Jekel, M. 2006 Organic Pollutants in the Water Cycle. WILEY-VCH Verlag GmbH & Co KGaA, Weinheim.
22. Sayder, B., Kabasci, S., Vitz, H., Kiffmeyer, T. K. & Türk, J. 2008 Behandlung hochbelasteter Klinikabwasser-Teilströme. Entwicklung eines oxidativen Verfahrens vom Labormaßstab zur Demonstrationsanlage [in German]. GWF Wasser/Abwasser 149(7-8), 576-584.
23. Siegrist, H., Escher, B., Hollender, J., Krauss, M. P., Ort, C., Zimmermann, S., von Gunten, U. 2009 Full scale post-ozonation followed by sand filtration at WWTP Regensdorf (CH) for micropollutant removal and disinfection. In Oxidation Technologies for Water and Wastewater Treatment Executive Summaries of the 5th International Conference, 10th IOA-EA3G Berlin Conference, March 30-April 2 2009, Berlin 2009. Michael Sievers, Sven-Uwe Geissen, Sven Schäfer, Britta Kragert & Michael Niedermeiser (eds): CUTEC-Institut GmbH-1st Edition-Clausthal-Zellerfeld: Papierflieger, 2009. (CUTEC No 72).
24. Türk, J. 2007 Development and application of LC-MS/MS multimethods for the quantification of antibiotics and cytostatic drugs at occupational safety and environmental investigations [in German]. PhD Thesis, Department of Chemistry, University of Duisburg-Essen, Germany.